Faron Pharmaceuticals Oy (LON:FARN) Share Price Passes Above 50 Day Moving Average of $321.76

Faron Pharmaceuticals Oy (LON:FARNGet Rating)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 321.76 ($3.92) and traded as high as GBX 327 ($3.99). Faron Pharmaceuticals Oy shares last traded at GBX 317.50 ($3.87), with a volume of 10,600 shares changing hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a debt-to-equity ratio of 121.51, a quick ratio of 1.09 and a current ratio of 0.93. The stock has a 50 day moving average of GBX 321.76 and a 200 day moving average of GBX 257.31. The stock has a market capitalization of £201.61 million, a P/E ratio of -690.22 and a beta of 0.20.

About Faron Pharmaceuticals Oy

(Get Rating)

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies.

Featured Stories

Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.